Walnut peptide composition as well as preparation method and application thereof

Through the combination of walnut peptide, theanine extract and fructose, a clean and side-effect anti-fatigue functional beverage was prepared, which solved the problem of lack of such products on the market and achieved effective anti-fatigue effect and health The goal of beverages.

CN118903373APending Publication Date: 2024-11-08湖北安琪屈姑生物科技有限公司 +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410866262.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-28
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The market lacks anti-fatigue compositions or functional beverages that are formulated clean, side-effect-free, and existing compositions often contain harmful food additives such as caffeine, ascorbic acid and flavors, resulting in side effects on the body.

Method used

Walnut peptide, theanine extract and fructose oligosaccharide composition are prepared by leaching, membrane filtration and reverse osmosis concentration, etc., for the preparation of anti-fatigue functional beverages, avoiding additional additives, and using low-quality Polyfructose improves taste and promotes digestion and absorption.

Benefits of technology

It achieves the anti-fatigue effect of the formula clean and palatable, without side effects, enhances the anti-fatigue effect, and retains the substance activity to the greatest extent through low-temperature membrane filtration technology, ensuring the natural health of the beverage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004921652480000061
    Figure BDA0004921652480000061
  • Figure BDA0004921652480000101
    Figure BDA0004921652480000101
  • Figure BDA0004921652480000111
    Figure BDA0004921652480000111
Patent Text Reader

Abstract

The invention relates to a walnut peptide composition as well as a preparation method and application thereof, the walnut peptide composition comprises the following components in parts by weight: 15-25 parts of walnut peptide, 8-16 parts of theanine extract and 2-10 parts of fructo-oligosaccharide, and the walnut peptide comprises an amino acid sequence as shown in SEQ ID NO. 1: DFPFPSPF. The anti-fatigue effect of the walnut peptide composition is enhanced, dietary fibers can be supplemented, digestion and absorption are promoted, and the walnut peptide composition is beneficial to health.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of bioactive peptides, and particularly relates to a walnut peptide composition and a preparation method and application thereof. Background Art

[0002] Sports fatigue refers to the inability of muscles to maintain the required energy level after strenuous activity or exercise, usually manifested as muscle soreness, fatigue, and decreased exercise endurance. The mechanism of sports fatigue is very complex, and the more mainstream theories are the energy depletion theory and the metabolite accumulation theory. The energy depletion theory believes that high-intensity exercise will lead to the depletion of liver and muscle glycogen reserves and a significant decrease in blood sugar concentration, causing people to feel tired; the metabolite accumulation theory believes that glycogen is easily decomposed under anaerobic conditions to produce a large amount of lactic acid, and as the intensity of exercise increases, the lactic acid content in the body will increase, resulting in a decline in motor function and fatigue.

[0003] In recent years, there have been an endless stream of compositions and functional beverages that promote recovery from sports fatigue and delay sports fatigue. They can reduce fatigue in a short period of time. The main reason is that caffeine is added to the composition or functional beverage, which stimulates the liver to release glycogen to increase the body's energy, thereby achieving the effect of eliminating fatigue. However, long-term intake will increase people's cardiovascular burden and reduce the body's normal tolerance. In addition, ascorbic acid, citric acid, edible flavors, etc. are added to such compositions or functional beverages to improve the taste of the beverage, but these substances have the potential to corrode the enamel on the surface of teeth, change the color of teeth, and produce related side effects on the body. Therefore, the current market is in urgent need of a composition or functional beverage with a clean formula and no side effects that can resist fatigue. Summary of the invention

[0004] In view of the lack of anti-fatigue compositions with clean formula and no side effects in the current market, the present invention proposes a walnut peptide composition and a preparation method and application thereof, which has a clean formula, no additional food additives (including pigments, flavors, etc.), good palatability, can promote digestion and absorption, and is beneficial to health.

[0005] Specifically, the present invention provides the following technical solutions:

[0006] In a first aspect, the present invention provides a walnut peptide composition, characterized in that, by weight, it comprises 15-25 parts of walnut peptide, 8-16 parts of theanine extract and 2-10 parts of oligofructose, and the walnut peptide comprises the amino acid sequence shown in SEQ ID NO.1: DFPFPSPF.

[0007] Preferably, the walnut peptide composition is characterized in that, by weight, the composition comprises 18-22 parts of walnut peptide, 10-12 parts of theanine extract and 4-6 parts of oligofructose;

[0008] Preferably, the composition comprises 20 parts of walnut peptide, 12 parts of theanine extract and 6 parts of oligofructose by weight;

[0009] More preferably, the mass percentage of theanine contained in the theanine extract is 20-28%.

[0010] In a second aspect, the present invention provides a method for preparing the walnut peptide composition, comprising mixing walnut peptide, theanine extract and oligofructose in proportion.

[0011] Preferably, in the method for preparing the walnut peptide composition, the theanine extract is prepared by the following steps:

[0012] (1) extracting tea leaves in pure water to obtain an extract;

[0013] (2) The extract is concentrated by centrifugation, membrane filtration and reverse osmosis in sequence.

[0014] Preferably, in the method for preparing the walnut peptide composition, in step (1), the extraction time is 10 to 80 minutes; preferably, the extraction temperature is 40 to 90°C.

[0015] Preferably, in the method for preparing the walnut peptide composition, in step (1), the solid-liquid ratio (g / L) of tea leaves to pure water is: (0.8-1.2): (10-30).

[0016] Preferably, in the preparation method of the walnut peptide composition, in step (1), the tea leaves are selected from one or both of fresh tea leaves and dried tea leaves; preferably, the tea leaves are selected from one or more of green tea, black tea, dark tea, oolong tea or white tea.

[0017] Preferably, in the method for preparing the walnut peptide composition, in step (2), a combined membrane is used for filtration, and the combined membrane is a combination of a ceramic membrane and an ultrafiltration membrane;

[0018] Preferably, the pore size of the ceramic membrane is 10 to 50 nm;

[0019] More preferably, the pore size of the ultrafiltration membrane is 4000-5000 Da.

[0020] Preferably, in the method for preparing the walnut peptide composition, the temperature of the reverse osmosis concentration in step (2) is 40-60° C.; preferably, the reverse osmosis concentration uses a reverse osmosis membrane; further preferably, the pore size of the reverse osmosis membrane is 0.1-0.3 nm.

[0021] Preferably, the method for preparing the walnut peptide composition further comprises a drying step after step (2);

[0022] Preferably, the drying is performed by spray drying.

[0023] In a third aspect, the present invention provides a walnut peptide composition prepared by the preparation method of the walnut peptide composition.

[0024] In a fourth aspect, the present invention provides an anti-fatigue functional beverage, characterized in that it comprises the walnut peptide composition.

[0025] Preferably, the anti-fatigue functional beverage is characterized in that the anti-fatigue functional beverage further comprises water;

[0026] Preferably, the composition comprises 15-25 parts of walnut peptide, 8-16 parts of theanine extract, 2-10 parts of oligofructose and 120-150 parts of water, by weight;

[0027] Further preferably, the composition comprises 18-22 parts of walnut peptide, 10-12 parts of theanine extract, 4-6 parts of oligofructose and 130-140 parts of water, by weight;

[0028] More preferably, based on weight, it includes 20 parts of walnut peptide, 12 parts of theanine extract, 6 parts of oligofructose and 135 parts of water.

[0029] In a fifth aspect, the present invention provides a method for preparing the anti-fatigue functional beverage, comprising mixing and filtering walnut peptides, theanine extract, oligofructose and water, and then homogenizing and sterilizing the mixture.

[0030] Preferably, in the method for preparing the anti-fatigue functional beverage, the filtration is performed by ultrafiltration membrane filtration, and the pore size of the ultrafiltration membrane is 4500-5500Da;

[0031] Preferably, the homogenization is carried out using a high-pressure homogenizer with a homogenization pressure of 10 to 30 MPa;

[0032] More preferably, the sterilization is carried out by membrane filtration, and the pore size of the membrane is 0.2-0.4 μm.

[0033] In a sixth aspect, the present invention provides application of the walnut peptide composition in anti-fatigue products.

[0034] Preferably, the use of the walnut peptide composition in an anti-fatigue product is characterized in that the anti-fatigue product is a food, a beverage, a health product or a medicine;

[0035] Preferably, the beverage is an anti-fatigue functional beverage.

[0036] Beneficial effects of the present invention:

[0037] The present invention can exert the synergistic effect of the two anti-fatigue active ingredients, walnut peptide and theanine, to enhance the anti-fatigue effect. At the same time, the addition of oligofructose (as a prebiotic) can increase the sweetness and improve the palatability of the beverage on the one hand, and supplement dietary fiber on the other hand, promote digestion and absorption, and be beneficial to health.

[0038] The functional beverage of the present invention has a clean formula, does not contain additional food additives (including pigments, flavors, etc.), and through low-temperature membrane filtration sterilization technology, can avoid high temperature and ensure the activity of substances to the greatest extent, thereby producing a functional beverage with a clean formula, good palatability, natural health and anti-fatigue activity. DETAILED DESCRIPTION

[0039] The technical solution of the present invention is further described in detail below in conjunction with specific embodiments and comparative examples, but the present invention is not limited to the following technical solution.

[0040] The invention provides a walnut peptide composition, which comprises 15-25 parts of walnut peptide, 8-16 parts of theanine extract and 2-10 parts of oligofructose by weight, and the walnut peptide comprises an amino acid sequence shown in SEQ ID NO.1: DFPFPSPF.

[0041] The detection and determination method of the walnut peptide is disclosed in Example 6 of the patent application with publication number CN117486971A.

[0042] The walnut peptide of the present invention is prepared by an artificial synthesis method, and the artificial synthesis method is:

[0043] (1) Weigh 1-1.5 g of 2-Cl(Trt)-Cl resin into a 150 mL reactor, add dichloromethane (DCM) and soak at 20-30°C for 30 min;

[0044] (2) washing the resin in step 1 with dimethylformamide (DMF) and then draining it, repeating this process 4 times until the resin is drained;

[0045] (3) Weigh 0.1-0.5 mmol Fmoc-Phe(tBu)-OH (the first amino acid at the C-terminus), DCM and N,N-diisopropylethylamine (DIEA) into the reactor, and then place the reactor in a shaker at 20-30°C for 2 hours;

[0046] (4) Use a pipette to add 0.5 mL of DIEA, 0.5 mL of acetic anhydride, and 2 mL of DCM mixed reagent (DIEA:MEOH:DCM=1:1:2) and react for 20 min to block the unreacted groups on the resin;

[0047] (5) Add an appropriate amount of 20% piperidine solution (piperidine / DMF = 1:4) to the reactor, which is 3 times the volume of the resin, and react for 20 minutes to remove the Fmoc protecting group. After deprotection, wash with DMF 4 times and then drain;

[0048] (6) Take 10 to 20 resin pellets from the reactor using a long-necked pipette and detect them using the ninhydrin method. If the resin has color, it indicates that the deprotection is successful. If it does not, repeat the deprotection-washing-detection operation.

[0049] (7) Weigh an appropriate amount of 0.3-1.5 mmol Fmoc-Pro-OH (the second amino acid at the C-terminus), an appropriate amount of 1-hydroxybenzotriazole (HOBT) and N,N'-diisopropylcarbodiimide (DIC) and add them into the reactor, and then place the reactor in a shaker at 20-30°C for reaction for 1 hour;

[0050] (8) Wash the resin with DMF and then drain it. Repeat this process 4 times until the resin is drained.

[0051] (9) Take 10 to 20 resin pellets from the reactor using a long-necked pipette and test them using the ninhydrin method. If the resin is colored, it means that the condensation is incomplete and the reaction should be continued; if the resin is colorless, it means that the reaction is complete.

[0052] (10) Repeat steps 7-9 to sequentially connect another 6 amino acids to the reaction resin until the synthesis is completed, remove Fmoc, wash with DMF 4 times, and wash with DCM for the last time, and finally drain the resin to obtain a resin peptide;

[0053] (11) The resin peptide was cleaved with trifluoroacetic acid (TFA:TIS (triisopropylsilane):H2O=95:2.5:2.5), precipitated with glacial ether, and the precipitate was collected and washed three times with glacial ether;

[0054] (12) The antioxidant peptides were purified by high performance liquid chromatography (HPLC) and then freeze-dried.

[0055] HPLC purification conditions: mobile phase A: ultrapure water; mobile phase B: acetonitrile; chromatographic column: C18 reverse phase column (Acclaim PepMap RSLC, 75 μm × 25 cm C18-2 μm Flow rate: 1 ml / min; gradient elution scheme: 0 min: 95% A + 5% B-60 min: 60% A + 40% B. After HPLC chromatographic peak analysis, the required fractions are collected, and the purity of the peptide after purification can reach more than 99%.

[0056] Freeze-drying conditions: vacuum freeze dryer, cold trap temperature: -60°C; vacuum degree: 10Pa; freeze-drying time: 48h.

[0057] In some specific embodiments, the theanine extract in the walnut peptide composition can be obtained by commercial purchase or other conventional preparation methods.

[0058] In some specific embodiments, the weight proportion of theanine extract in the walnut peptide composition can be any two values ​​between 8 and 16: 8, 9, 10, 11, 12, 13, 14, 15 or 16.

[0059] In some specific embodiments, the weight proportion of oligofructose in the walnut peptide composition can be any two values ​​between 2 and 10: 2, 3, 4, 5, 6, 7, 8, 9 or 10.

[0060] In some specific embodiments, the weight proportions of walnut peptides in the walnut peptide composition can be any two values ​​between 15-25: 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 or 25.

[0061] Unless otherwise specified, the various reagents / instruments used in the examples and comparative examples of the present invention are conventional commercially available products. The sources of experimental materials and instrument information used in the present invention are shown in Table 1 below:

[0062] Table 1

[0063]

[0064] Example 1

[0065] 1. Preparation of theanine extract: 1000g of green tea is used as raw material, pure water is used as extraction solvent, and the solution is extracted for 10min at a solid-liquid ratio (g / L) of 0.8:10 and a temperature of 40°C. The extracted solution is centrifuged in a centrifuge at a speed of 5000r / min, and filtered through a combination of a ceramic membrane and an ultrafiltration membrane, wherein the pore size of the ceramic membrane is 10nm and the pore size of the ultrafiltration membrane is 4000Da. The combination of ceramic membrane and ultrafiltration membrane can effectively remove macromolecules such as protein and starch in tea extract, reduce the loss of theanine effective ingredients, improve the extraction rate of theanine, and ensure the service life of the membrane and shorten the extraction time. After filtration, it is concentrated by a reverse osmosis membrane with a pore size of 0.1nm and a concentration temperature of 40°C. The concentrated product is spray dried with an inlet air temperature of 160°C and an outlet air temperature of 70°C. After drying, 680g of theanine extract is obtained, and the mass percentage of theanine in the theanine extract is 20%. Theanine was determined according to the national standard “GB / T23193-2017 Determination of theanine in tea by high performance liquid chromatography”.

[0066] 2. Preparation of walnut peptide composition: 15 parts by weight of walnut peptide, 2 parts by weight of oligofructose and 8 parts by weight of theanine extract obtained above were mixed to obtain a walnut peptide composition.

[0067] 3. Preparation of anti-fatigue functional beverage: 25 parts by weight of the walnut peptide composition obtained above were mixed with 120 parts by weight of water to prepare 500 g of anti-fatigue functional beverage. After mixing, ultrafiltration membrane was used for filtration, and the pore size of the ultrafiltration membrane was 45000 Da. After filtration, a high-pressure homogenizer was used for homogenization, and the homogenization pressure was 10 MPa. Finally, membrane filtration was used for sterilization, and the membrane pore size was 0.2 μm. Canning was performed to obtain a beverage.

[0068] Example 2

[0069] 1. Preparation of theanine crude extract: 1000g green tea is used as raw material, pure water is used as extraction solvent, and the solution is extracted for 40min under the conditions of solid-liquid ratio (g / L) of 1:20 and temperature of 65°C; the extracted solution is centrifuged in a centrifuge at a speed of 5000r / min, and filtered through a ceramic membrane and an ultrafiltration membrane combination, wherein the pore size of the ceramic membrane is 20nm and the pore size of the ultrafiltration membrane is 4500Da. After filtration, it is concentrated by a reverse osmosis membrane, the pore size of the reverse osmosis membrane is 0.2nm, and the concentration temperature is 50°C. The concentrated product is spray dried with an inlet air temperature of 160°C and an outlet air temperature of 70°C. After drying, 714g of theanine extract is obtained, and the mass percentage of theanine in the theanine extract is 25%.

[0070] 2. Preparation of walnut peptide composition: 20 parts by weight of walnut peptide, 6 parts by weight of oligofructose and 12 parts by weight of theanine extract obtained above were mixed to obtain a walnut peptide composition.

[0071] 3. Preparation of anti-fatigue functional beverage: 38 parts by weight of the walnut peptide composition obtained above was mixed with 135 parts by weight of water to prepare 500 g of anti-fatigue functional beverage. After mixing, ultrafiltration membrane was used for filtration, and the pore size of the ultrafiltration membrane was 5000 Da. After filtration, a high-pressure homogenizer was used for homogenization, and the homogenization pressure was 20 MPa. After homogenization, membrane filtration was used for sterilization, and the membrane pore size was 0.3 μm. Canning was performed to obtain a beverage.

[0072] Example 3

[0073] 1. Preparation of theanine crude extract: 1000g green tea is used as raw material, pure water is used as extraction solvent, and the solution is extracted for 80min at a solid-liquid ratio (g / L) of 1.2:30 and a temperature of 90°C; the extracted solution is centrifuged in a centrifuge at a speed of 5000r / min, and filtered through a ceramic membrane and an ultrafiltration membrane combination, wherein the ceramic membrane has a pore size of 50nm and the ultrafiltration membrane has a pore size of 5000Da. After filtration, it is concentrated through a reverse osmosis membrane, the pore size of the reverse osmosis membrane is 0.3nm, and the concentration temperature is 60°C. The concentrated product is spray-dried, with an inlet air temperature of 160°C and an outlet air temperature of 70°C. After drying, 736g of theanine extract is obtained, and the mass percentage of theanine in the theanine extract is 28%.

[0074] 2. Preparation of walnut peptide composition: 25 parts by weight of walnut peptide, 10 parts by weight of oligofructose and 16 parts by weight of theanine extract obtained above were mixed to obtain a walnut peptide composition.

[0075] 3. Preparation of anti-fatigue functional beverage: 51 parts by weight of the walnut peptide composition obtained above were mixed with 150 parts by weight of water to prepare 500 g of anti-fatigue functional beverage. After mixing, ultrafiltration membrane was used for filtration, and the pore size of the ultrafiltration membrane was 5500 Da. After filtration, a high-pressure homogenizer was used for homogenization, and the homogenization pressure was 30 MPa. After homogenization, membrane filtration was used for sterilization, and the membrane pore size was 0.4 μm. Canning was performed to obtain a beverage.

[0076] Example 4

[0077] 1. Preparation of theanine crude extract: same as Example 2.

[0078] 2. Preparation of walnut peptide composition: 18 parts by weight of walnut peptide, 4 parts by weight of oligofructose and 10 parts by weight of theanine extract obtained above were mixed to obtain a walnut peptide composition.

[0079] 3. Preparation of anti-fatigue functional beverage: 32 parts by weight of the walnut peptide composition obtained above were mixed with 130 parts by weight of water to prepare 500 g of anti-fatigue functional beverage. After mixing, ultrafiltration membrane was used for filtration, and the pore size of the ultrafiltration membrane was 5000 Da. After filtration, a high-pressure homogenizer was used for homogenization, and the homogenization pressure was 20 MPa. Finally, membrane filtration was used for sterilization, and the membrane pore size was 0.3 μm. Canning was performed to obtain a beverage.

[0080] Example 5

[0081] 1. Preparation of theanine crude extract: same as Example 2.

[0082] 2. Preparation of walnut peptide composition: 22 parts by weight of walnut peptide, 6 parts by weight of oligofructose and 12 parts by weight of theanine extract obtained above were mixed to obtain a walnut peptide composition.

[0083] 3. Preparation of anti-fatigue functional beverage: 40 parts by weight of the walnut peptide composition obtained above was mixed with 140 parts by weight of water to prepare 500 g of anti-fatigue functional beverage. After mixing, ultrafiltration membrane was used for filtration, and the pore size of the ultrafiltration membrane was 5000 Da. After filtration, a high-pressure homogenizer was used for homogenization, and the homogenization pressure was 20 MPa. Finally, membrane filtration was used for sterilization, and the membrane pore size was 0.3 μm. Canning was performed to obtain a beverage.

[0084] Comparative Example 1

[0085] Without adding theanine and oligofructose, only walnut peptide was added to prepare the functional beverage, and other proportions and preparation methods were exactly the same as the preparation process of Example 2.

[0086] Comparative Example 2

[0087] Without adding walnut peptide and oligofructose, only theanine was added to prepare the functional beverage, and other proportions and preparation methods were exactly the same as the preparation process of Example 2.

[0088] Comparative Example 3

[0089] Walnut peptide and theanine were not added, and only oligofructose was added to prepare the functional beverage. Other proportions and preparation methods were exactly the same as those in Example 2.

[0090] Comparative Example 4

[0091] No walnut peptide was added, and only theanine and oligofructose were added to prepare the functional beverage. Other proportions and preparation methods were exactly the same as those in Example 2.

[0092] Comparative Example 5

[0093] The functional beverage was prepared without adding theanine, and only walnut peptide and oligofructose were added. Other proportions and preparation methods were exactly the same as those in Example 2.

[0094] Comparative Example 6

[0095] Without adding oligofructose, only theanine and walnut peptide were added to prepare the functional beverage, and other proportions and preparation methods were exactly the same as the preparation process of Example 2.

[0096] Comparative Example 7

[0097] Only the walnut peptide was replaced with the Rhodiola rosea extract, a plant extract that also has anti-fatigue effects, and the other proportions and preparation methods were exactly the same as those in Example 2.

[0098] Comparative Example 8

[0099] Compared with Example 2, 20 parts of walnut peptide, 20 parts of theanine extract and 20 parts of oligofructose were taken, and the other proportions and preparation methods were exactly the same as those in Example 2.

[0100] Comparative Example 9

[0101] Compared with Example 2, 20 parts of walnut peptide, 4 parts of theanine extract, 1 part of oligofructose and 135 parts of water were mixed, and other proportions and preparation methods were exactly the same as the preparation process of Example 2.

[0102] Experimental Example 1 Sensory Evaluation Experiment

[0103] A sensory evaluation standard was formulated to score the color, flavor, taste, and texture of the functional beverages prepared in Examples 1-5 and Comparative Examples 1-9. The evaluation standard is shown in Table 2. A 10-member evaluation team was formed. The team evaluation personnel independently evaluated, and the results are shown in Table 3.

[0104] As can be seen from Table 2, the scores and overall scores of Examples 1-5 are higher than those of Comparative Examples 1-9, among which the functional beverage prepared in Example 2 has the best effect. By observing Comparative Examples 1, 2 and 6, it is found that when oligofructose is not added, the overall score of the prepared beverage decreases, which shows that oligofructose can significantly improve the taste of the beverage, and the quality of the functional beverage prepared by the compounding ratio of walnut peptide, theanine and oligofructose of the present invention is significantly improved.

[0105] Table 2 Sensory evaluation standard table of anti-fatigue beverages

[0106] project Evaluation Criteria Weight Color Uniform color 20% Flavor Has a light tea fragrance, no bad taste or smell 30% Taste Delicate and smooth taste, moderate sweetness 30% Organization Status The liquid is uniform and fine, with moderate consistency and no precipitation or floating 20%

[0107] Table 3 Sensory evaluation results of anti-fatigue beverages

[0108]

[0109]

[0110] Experimental Example 2: Anti-fatigue experiment in mice

[0111] This experiment was completed by China Three Gorges University, batch number 2023020V

[0112] 1. Animal grouping and drug administration

[0113] 140 BALB / c mice (18g-25g, 8-9 weeks, half male and half female) were randomly divided into 14 groups, 10 mice in each group, all experimental mice were pre-fed for one week before the formal experiment, and mice were free to drink water during the experiment. Examples 1-5, comparative examples 1-9, blank controls and positive controls were given oral administration to each experimental group of mice at a dose of 400 mg / kg, and body weight was monitored daily for 3 consecutive weeks. Among them, the blank control group was gavaged with normal saline daily, and the positive control group was gavaged with Red Bull functional drink daily.

[0114] 2. Pole climbing experiment

[0115] Each group of mice was gavaged daily for 30 minutes, and then placed on a stainless steel metal climbing pole, which was 35 cm long and 8 mm in diameter, with the bottom fixed on a firm base. Mouse feed was used to lure the mice to prevent them from staying on the top of the metal pole for a long time. The time when the mice fell from the climbing pole (the body began to contact the base of the climbing pole) was recorded, and each mouse was recorded three times in a row, and the average time was calculated as the climbing time of the mice.

[0116] 3. Swimming training and exhaustive swimming test

[0117] Swimming training: The swimming box is a homemade 60cm×40cm×40cm water tank with a water depth of 30cm and a water temperature of 23±2℃. Each time, the mice swim for 20 minutes and stir with a glass rod to prevent them from floating on the water for a long time. After the swimming training, the mice are fished out, wiped with paper towels, and blown dry with a hair dryer before returning to the cage for breeding. On the 21st day of continuous gavage, 30 minutes after the last gavage, a 5% lead wire was tied to the middle of the tail of each group of mice, and they were placed in 23±2℃ water to swim, and the water surface was stirred with a glass rod. When the nose of the mouse sank under water for 10 seconds and could not float up, the mouse was judged to be exhausted, and the time from the beginning of swimming to exhaustion was recorded.

[0118] 4. Determination of blood urea nitrogen (BUN), lactic acid (LA), and creatine kinase (CK) in mice

[0119] After weight-loaded swimming to exhaustion, the mice were quickly fished out and blood was collected from the eyeballs. The blood collected in the heparin anticoagulation tube was centrifuged at 3000rpm for 10 minutes to obtain the supernatant, which was the plasma. 20μL of plasma was aspirated and the plasma urea value was determined using a plasma urea determination kit (diacetyl-oxime method). The specific operation was carried out according to the instructions of the kit. After the blood in the non-anticoagulation tube was allowed to stand in a 4° refrigerator for 2 hours, it was centrifuged at 3000rpm for 10 minutes. The supernatant was serum. Serum LA and CK were determined according to the kit instructions of the lactate test kit and the creatine kinase test kit, respectively.

[0120] 5. Determination of liver glycogen and muscle glycogen

[0121] After the mice were exhausted from weight-bearing swimming and blood was collected from the eyeballs, the experimental animals were immediately killed, and the liver tissue and calf gastrocnemius muscle tissue were taken out. 0.1-0.2g of tissue samples were weighed respectively and placed in a 10ml test tube; 0.75ml of extract was added, and the mixture was boiled in a boiling water bath for 20min, and the test tube was shaken once every 5min to mix thoroughly; after the tissue was completely dissolved, the test tube was removed and cooled, and the volume was made up to 5ml with distilled water, mixed, and centrifuged at 25℃ and 8000r / min for 10min. The supernatant was taken and the liver glycogen and muscle glycogen contents were determined respectively according to the anthrone method principle and the instructions in the liver / muscle glycogen kit.

[0122] 6. Experimental results

[0123] The pole climbing test is a common behavioral test, which is usually used to evaluate the coordination and athletic ability of mice; the exhaustive swimming test can reflect the overall athletic ability and physical condition of mice by observing the vigor and endurance level of swimming. Mice with higher vigor and endurance will swim for a longer time, while mice with poor physical strength will swim for a shorter time.

[0124] As can be seen from Table 4, the five groups of embodiments are significantly improved compared with the blank control and the positive control, among which, the anti-fatigue effect of embodiment 2 is the best. Compared with the blank control, its pole climbing time and exhaustive swimming time are increased by 98.8% and 94.3%, respectively; compared with the positive control, its pole climbing time and exhaustive swimming time are increased by 24.8% and 34.8%, respectively, which shows that the beverage prepared by the present invention has a certain anti-fatigue effect and is better than the anti-fatigue functional beverage on the market. In addition, the anti-fatigue effect of the beverage prepared by the comparative example on mice is weaker than that of the embodiment, indicating that the present invention has a certain enhancement effect on the body's anti-fatigue ability.

[0125] Table 4 Effects of functional drinks on climbing pole time and exhaustive swimming time of mice

[0126]

[0127]

[0128] Glycogen is a polysaccharide stored in the liver that can be broken down into glucose when energy is needed to provide energy supply to the body. Glycogen provides energy supply to the liver and the whole body. When glycogen reserves are low, mice will experience exercise fatigue more quickly because of insufficient energy supply. On the contrary, higher glycogen levels can delay the onset of fatigue and enable mice to maintain exercise for longer periods of time. After exercise, glycogen will be resynthesized to restore and replenish reserves. Higher glycogen levels can speed up recovery after exercise, allowing mice to recover their strength and adjust their metabolic state faster.

[0129] Muscle glycogen is one of the main sources of energy for muscles. During high-intensity or long-term exercise, muscles need a lot of energy to support muscle contraction and movement. When muscle glycogen reserves are sufficient, they can provide a continuous energy supply and delay the occurrence of muscle fatigue. When the muscle glycogen level drops, the energy supply to the muscles is insufficient, and the rate of muscle fatigue will accelerate. Therefore, the higher the muscle glycogen content, the better its anti-fatigue effect.

[0130] Lactic acid content has an important influence on the anti-fatigue effect. When the body is exercising, the decomposition of sugar in the body to provide energy is accelerated, and insufficient oxygen supply leads to anaerobic glycolysis of sugar to produce lactic acid. The lactic acid content in the blood increases, which increases the H+ concentration in the muscles, decreases the pH value, reduces the exercise capacity, and produces fatigue.

[0131] Urea nitrogen content is an indicator of nitrogen metabolism status, which reflects the level of protein breakdown and nitrogen excretion. Urea nitrogen content is negatively correlated with the body's tolerance because, during fatigue, muscles may be in a negative nitrogen balance state, that is, protein breakdown exceeds synthesis. This may lead to an increase in urea nitrogen content and increased urinary nitrogen excretion, further affecting nitrogen metabolism and muscle function.

[0132] Creatine Kinase (CK) is also called creatine phosphokinase. Under normal circumstances, most creatine kinase is located in muscle cells. Elevated creatine kinase in the blood generally indicates that muscle damage has occurred or is occurring. Exercise can lead to a significant increase in creatine kinase, and the more intense and longer the exercise, the more obvious the increase in creatine kinase. Creatine kinase is also an important indicator for evaluating anti-fatigue effects.

[0133] It can be seen from Table 5 that compared with the blank control, positive control and comparative example, in the three groups of embodiments, the muscle glycogen and liver glycogen reserves of mice were increased, and the lactic acid, serum urea nitrogen and creatine kinase contents were reduced, indicating that the beverage of the present invention has a certain anti-fatigue effect.

[0134] Table 5 Effects of functional beverages on relevant biochemical indicators of mice

[0135]

[0136]

[0137] Experimental Example 3 Effect of in vitro intestinal bacterial growth

[0138] Bifidobacterium and Escherichia coli were cultured in TPY and LB culture media for 12 hours respectively, and used as bacterial liquid for standby. 50 mL of TPY culture medium and 50 mL of LB culture medium were prepared respectively, with 2% glucose as the control group, and 5 mL of the anti-fatigue functional beverage in Examples 1 to 5 and Comparative Examples 1 to 9 was added to the test group respectively. 0.5 mL of the prepared bifidobacterium and Escherichia coli bacterial liquid was inoculated in TPY and LB culture media respectively, and the absorbance of each culture medium was detected every 12 hours.

[0139] Determination of absorbance: After shaking the bacterial culture solution, immediately extract 1 mL and put it into 4 mL of sterile water, measure the A value at 600 nm, and use the initial A0 value of each tube of bacterial culture solution as the control. Record the growth value ΔA relative to the initial A0 value after 12, 24, and 48 hours of culture.

[0140] There are nearly 500 kinds of bacteria in the intestines of normal adults, and the balance of the flora is very important for maintaining human health. Bifidobacterium and Escherichia coli are respectively the dominant anaerobic bacteria and aerobic bacteria in the intestines, among which Bifidobacterium is one of the important signs of human health. 12 , ΔA 24 , ΔA 24 All of them showed a growth-enhancing effect, indicating that the addition of oligofructose has the effect of promoting the growth of bifidobacteria, and the ΔA in the examples is higher than that in the blank control group. 12 , ΔA 24 , ΔA 24 It showed a strong inhibitory effect, indicating that the addition of oligofructose has the effect of inhibiting the growth of Escherichia coli, and the ΔA in the examples was lower than that in the blank control group. Therefore, adding oligofructose to the functional beverage has the effect of regulating intestinal flora.

[0141] Table 6 Effect of functional beverages on the growth of Bifidobacterium

[0142]

[0143]

[0144] Table 7 Effect of functional beverages on the growth of Escherichia coli

[0145]

[0146]

Claims

1. A walnut peptide composition, characterized in that: By weight, it comprises 15-25 parts of walnut peptide, 8-16 parts of theanine extract and 2-10 parts of oligofructose, and the walnut peptide comprises the amino acid sequence shown in SEQ ID NO.1: DFPFPSPF.

2. The walnut peptide composition according to claim 1, characterized in that The composition comprises 18-22 parts of walnut peptide, 10-12 parts of theanine extract and 4-6 parts of oligofructose by weight; Preferably, the composition comprises 20 parts of walnut peptide, 12 parts of theanine extract and 6 parts of oligofructose by weight; More preferably, the mass percentage of theanine contained in the theanine extract is 20-28%.

3. A method for preparing the walnut peptide composition according to claim 1 or 2, comprising mixing walnut peptide, theanine extract and oligofructose in proportion.

4. The method for preparing the walnut peptide composition according to claim 3, wherein: The theanine extract is prepared by the following steps: (1) extracting tea leaves in pure water to obtain an extract; (2) The extract is concentrated by centrifugation, membrane filtration and reverse osmosis in sequence.

5. The method for preparing a walnut peptide composition according to claim 4, wherein in step (1), the extraction time is 10 to 80 minutes; preferably, the extraction temperature is 40 to 90°C.

6. The method for preparing a walnut peptide composition according to claim 4 or 5, wherein in step (1), the solid-liquid ratio (g / L) of tea leaves to pure water is: (0.8-1.2): (10-30).

7. The method for preparing a walnut peptide composition according to any one of claims 4 to 6, wherein in step (1), the tea leaves are selected from one or both of fresh tea leaves and dried tea leaves; preferably, the tea leaves are selected from one or more of green tea, black tea, dark tea, oolong tea or white tea.

8. The method for preparing a walnut peptide composition according to any one of claims 4 to 7, wherein in step (2), a combined membrane is used for filtration, and the combined membrane is a combination of a ceramic membrane and an ultrafiltration membrane; Preferably, the pore size of the ceramic membrane is 10 to 50 nm; More preferably, the pore size of the ultrafiltration membrane is 4000-5000 Da.

9. According to the method for preparing a walnut peptide composition according to any one of claims 4 to 8, the temperature of the reverse osmosis concentration in step (2) is 40 to 60°C; preferably, the reverse osmosis concentration uses a reverse osmosis membrane; further preferably, the pore size of the reverse osmosis membrane is 0.1 to 0.3 nm.

10. The method for preparing the walnut peptide composition according to any one of claims 4 to 9, further comprising a drying step after step (2); Preferably, the drying is performed by spray drying.

11. A walnut peptide composition prepared by the method for preparing a walnut peptide composition according to any one of claims 3 to 10.

12. An anti-fatigue functional beverage, characterized in that: The invention comprises a walnut peptide composition according to any one of claims 1, 2 or 11.

13. The anti-fatigue functional beverage according to claim 12, characterized in that: The anti-fatigue functional beverage also includes water; Preferably, the composition comprises 15-25 parts of walnut peptide, 8-16 parts of theanine extract, 2-10 parts of oligofructose and 120-150 parts of water, by weight; Further preferably, the composition comprises 18-22 parts of walnut peptide, 10-12 parts of theanine extract, 4-6 parts of oligofructose and 130-140 parts of water, by weight; More preferably, based on weight, it includes 20 parts of walnut peptide, 12 parts of theanine extract, 6 parts of oligofructose and 135 parts of water.

14. A method for preparing the anti-fatigue functional beverage according to claim 12 or 13, comprising mixing walnut peptide, theanine extract, oligofructose and water, filtering, and homogenizing and sterilizing to obtain the beverage.

15. The method for preparing the anti-fatigue functional beverage according to claim 14, wherein: The filtration is carried out by ultrafiltration membrane, and the pore size of the ultrafiltration membrane is 4500~5500Da; Preferably, the homogenization is carried out using a high-pressure homogenizer with a homogenization pressure of 10 to 30 MPa; More preferably, the sterilization is carried out by membrane filtration, and the pore size of the membrane is 0.2-0.4 μm.

16. Use of the walnut peptide composition according to claim 1, 2 or 11 in anti-fatigue products.

17. The use of the walnut peptide composition according to claim 16 in anti-fatigue products, characterized in that: The anti-fatigue product is food, beverage, health product or medicine; Preferably, the beverage is an anti-fatigue functional beverage.